MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Gender-Based Differences in Parkinson’s Disease Hospitalization: A Nationwide and Single Center Study

    Z. Xu, N. Bujala, A. Jain, E. Spirollari, A. Sacknovitz, A. Jiang, F. Al-Mufti, R. Fekete (New York, USA)

    Objective: To analyze hospital admission patterns among patients with Parkinson’s Disease (PD), comparing demographic characteristics, reasons for admission, length of stay, and discharge disposition between…
  • 2025 International Congress

    Unraveling Parkinson’s Disease Heterogeneity: Variability in Dopaminergic Medication Response Over Five Years – A Cluster Analysis of PPMI Data

    N. Rajabli, M. Vakhshoori, A. Espay, J. Jones, A. Baghaei, K. Dashtipour (Loma Linda, USA)

    Objective: We sought to examine which demographic, genetic, and clinical characteristics inParkinson’s disease (PD) are associated with differences in levodopa equivalent daily dose(LEDD) at five…
  • 2025 International Congress

    Absence of identifiable neuropathological correlates of cognitive impairment in multiple system atrophy

    S. Radmard, T. Ma, J. Agin-Liebes (Atlanta, USA)

    Objective: To analyze neuropathological correlates of cognitive impairment in multiple system atrophy (MSA) and characterize the affected cognitive domains. Background: Current MSA census criteria delineate…
  • 2025 International Congress

    Parkinson’s Exercise Guidelines: From Outdated to Updated

    M. Rafferty, L. Hoffman, L. Krasucki, D. Corcos (Chicago, USA)

    Objective: To align the 2021 Parkinson’s Exercise Guidelines with current evidence and stakeholder feedback. Background: In 2021, the Parkinson’s Foundation, in partnership with the American…
  • 2025 International Congress

    A personalized gait signature assay in Parkinson’s disease

    H. Babcock, J. Stephen, V. Vanderhorst (Boston, USA)

    Objective: To establish a personalized gait signature assay to inform on progression, phenotype and effects of intervention of gait abnormalities in PD. Background: Gait signatures…
  • 2025 International Congress

    Non-motor Symptoms in Parkinson Disease: A Target for Neuropalliative Care Intervention

    J. Acquaviva, S. Maguire, Y. Xu, E. Feinstein (Newark, USA)

    Objective: To identify various non-motor symptoms experienced by individuals with PD and to assess the likelihood of these symptoms being treated relative to individuals without…
  • 2025 International Congress

    Atypical Parkinsonism with LRRK2 Mutation Presenting as Multiple System Atrophy

    K. Makhoul, R. Ramdhani (Great neck, USA)

    Objective: We describe a rare case of atypical parkinsonism associated with leucine-rich repeat kinase 2 (LRRK2) gene mutation presenting with clinical features suggestive of multiple…
  • 2025 International Congress

    Unraveling the Genetic Architecture of Progressive Supranuclear Palsy in East Asians

    P. Chen, R. Lin, N. Lee, J. Hsu, C. Tai, R. Wu, H. Chiang, Y. Wu, C. Lu, H. Chang, T. Lee, Y. Chang, C. Lin (Taipei, Taiwan)

    Objective: We aim to elucidate the genetic architecture of progressive supranuclear palsy (PSP) in East Asians through whole-exome sequencing in a multi-center study in Taiwan.…
  • 2025 International Congress

    Spatial Metabolic Covariance Networks in PSP: Implications for Symptomatology and their Neural Basis

    B. Wang, W. Luo (Hangzhou, China)

    Objective: This study aimed to apply spatial ICA to 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) data from PSP patients and healthy controls (HCs) to identify…
  • 2025 International Congress

    Smoking and Genetic Interactions in Parkinson’s Disease

    JDJ. Wang, LL. Chan, E. Ng, K. Prakash, WL. Au, L. Tan, EK. Tan (Singapore, Singapore)

    Objective: To investigate the interaction between smoking and Asian-specific LRRK2 variants (G2385R and R1628P) in Parkinson’s disease (PD) risk, examining whether smoking modifies the genetic…
  • « Previous Page
  • 1
  • …
  • 385
  • 386
  • 387
  • 388
  • 389
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley